IRIS
MACCARRONE, MAURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.623
EU - Europa 1.644
AS - Asia 775
Continente sconosciuto - Info sul continente non disponibili 11
SA - Sud America 11
OC - Oceania 7
AF - Africa 5
Totale 23.076
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.609
SG - Singapore 405
UA - Ucraina 275
DE - Germania 256
IE - Irlanda 216
CN - Cina 215
IT - Italia 163
FR - Francia 146
SE - Svezia 133
KR - Corea 108
PL - Polonia 104
GB - Regno Unito 94
NL - Olanda 71
RU - Federazione Russa 67
FI - Finlandia 64
CZ - Repubblica Ceca 24
EU - Europa 10
KG - Kirghizistan 10
BE - Belgio 7
CA - Canada 7
JP - Giappone 7
AU - Australia 6
IL - Israele 6
BR - Brasile 5
IR - Iran 5
CL - Cile 4
DK - Danimarca 4
DM - Dominica 4
IN - India 4
RS - Serbia 4
VN - Vietnam 4
ZA - Sudafrica 4
CH - Svizzera 3
LT - Lituania 3
MX - Messico 3
ES - Italia 2
NO - Norvegia 2
RO - Romania 2
TW - Taiwan 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
CO - Colombia 1
ET - Etiopia 1
GR - Grecia 1
HK - Hong Kong 1
HU - Ungheria 1
IQ - Iraq 1
KW - Kuwait 1
LK - Sri Lanka 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PE - Perù 1
QA - Qatar 1
TH - Thailandia 1
TR - Turchia 1
Totale 23.076
Salva come PNG Salva come JPEG
Città #
Woodbridge 5.906
Wilmington 5.610
Houston 4.885
Fairfield 815
Ann Arbor 548
Chandler 397
Singapore 349
Ashburn 309
Seattle 298
Cambridge 254
Jacksonville 242
Dublin 207
Medford 161
Beijing 115
Kraków 101
Santa Clara 96
Lawrence 76
New York 72
Dearborn 64
Rome 45
Mülheim 37
San Diego 34
Menlo Park 31
Zhengzhou 29
Brno 24
Milan 18
Moscow 18
Redwood City 17
Norwalk 16
San Mateo 16
Saint Petersburg 15
University Park 15
Falls Church 14
Mountain View 14
London 12
Kunming 11
Nanjing 10
Palo Alto 10
Bari 9
Helsinki 9
Los Angeles 8
Nürnberg 8
Verona 8
Brussels 7
Boardman 6
Detroit 6
Hefei 6
Munich 6
Shanghai 6
Berlin 5
Guangzhou 5
Mcallen 5
San Francisco 5
Seoul 5
Chicago 4
Hounslow 4
Jinan 4
Redmond 4
Roseau 4
São Paulo 4
Toronto 4
Clearwater 3
Del Norte 3
Dong Ket 3
Fremont 3
Garden City 3
Hanover 3
Lappeenranta 3
Montague 3
Nashville 3
Rodigo 3
Royal Oak 3
Salt Lake City 3
Turin 3
Agliana 2
Alderley Edge 2
Auburn Hills 2
Belgrade 2
Bloemfontein 2
Buffalo 2
Carate Brianza 2
Cesano Maderno 2
Chongqing 2
Council Bluffs 2
Dongguan 2
Fars 2
Frederiksberg 2
Fuzhou 2
Giv‘atayim 2
Head of Westport 2
Hebei 2
Islington 2
Kilburn 2
Liverpool 2
Mexico City 2
Nanchang 2
New Bedfont 2
Philadelphia 2
Pune 2
Secaucus 2
Totale 21.114
Salva come PNG Salva come JPEG
Nome #
Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others? 509
Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA 456
Downstream effects of endocannabinoid on blood cells: Implications for health and disease 441
Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy. 439
Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis 432
Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors 431
Type-1 cannabinoid receptors colocalize with caveolin-1 in neuronal cells 425
The (endo)cannabinoid system in multiple sclerosis and amyotrophic lateral sclerosis 424
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis 424
High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients 423
Modulation of monocytes by bioactive lipid anandamide in multiple sclerosis involves distinct Toll-like receptors 423
Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour 417
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis. 417
Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice 417
Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis 411
TRPV1 channels facilitate glutamate transmission in the striatum 410
Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis 408
The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum 403
Subventricular zone neural progenitors protect striatal neurons from glutamatergic excitotoxicity 401
Trans-crocetin improves amyloid-β degradation in monocytes from Alzheimer's Disease patients 401
Urinary N-acetyl-beta-D-glucosaminidase concentration in patients with spinal cord injury: relationship with urodynamic parameters 400
Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum 399
Effects of palmitoylation of Cys(415) in helix 8 of the CB(1) cannabinoid receptor on membrane localization and signalling 399
TRPV1 channels regulate cortical excitability in humans 394
null 393
The endocannabinoid system in peripheral lymphocytes as a mirror of neuroinflammatory diseases 392
Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis 392
Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition 391
Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis 386
Endocannabinoids limit metabotropic glutamate 5 receptor-mediated synaptic inhibition of striatal principal neurons 383
Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice 383
Comment on "Cannabinoid receptor and N-acyl phosphatidylethanolamine phospholipase D--evidence for altered expression in multiple sclerosis" 382
Structure-to-function relationship of mini-lipoxygenase, a 60-kDa fragment of soybean lipoxygenase-1 with lower stability but higher enzymatic activity 380
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission 378
The endocannabinoid pathway in Huntington's disease: a comparison with other neurodegenerative diseases 377
Interleukin-1β Causes Anxiety by Interacting with the Endocannabinoid System 376
HIV-1 coat glycoprotein gp120 induces apoptosis in rat brain neocortex by deranging the arachidonate cascade in favor of prostanoids 371
The endocannabinoid system in targeting inflammatory neurodegenerative diseases 368
A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission 368
Pre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitis 365
Type-1 (CB1) cannabinoid receptor promotes neuronal differentiation and maturation of neural stem cells . 362
Stimulation of autophagy by rapamycin protects neurons from remote degeneration after acute focal brain damage 360
GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma 359
Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism 358
The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues for other neuroinflammatory diseases 354
Altered anandamide degradation in attention-deficit/hyperactivity disorder 352
Exploitation of the HIV-1 coat glycoprotein, gp120, in neurodegenerative studies in vivo 347
Functional characterization of putative cholesterol binding sequence (CRAC) in human type-1 cannabinoid receptor 341
In vitro and in vivo models of Huntington's disease show alterations in the endocannabinoid system 337
Cannabinoid receptor signaling in neurodegenerative diseases: a potential role for membrane fluidity disturbance 336
Lipid rafts regulate 2-arachidonoylglycerol metabolism and physiological activity in the striatum 334
Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis 333
TRPV1 channels regulate cortical excitability in humans 261
Potential for diagnosis versus therapy monitoring of attention deficit hyperactivity disorder: a new epigenetic biomarker interacting with both genotype and auto-immunity 252
Early alteration of distribution and activity of hippocampal type-1 cannabinoid receptor in Alzheimer's disease-like mice overexpressing the human mutant amyloid precursor protein 207
CSF levels of the endocannabinoid anandamide are reduced in patients with untreated narcolepsy type 1: a pilot study 188
From Traumatic Childhood to Cocaine Abuse: The Critical Function of the Immune System 173
Essential Dietary Bioactive Lipids in Neuroinflammatory Diseases 164
Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474 159
Platelet activation: a new vascular activity of anandamide [2] 138
Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity 133
Advances in the discovery of fatty acid amide hydrolase inhibitors: what does the future hold? 125
Development of novel multipotent compounds modulating endocannabinoid and dopaminergic systems 113
Characterization of Endocannabinoid System and Interleukin Profiles in Ovine AEC: Cannabinoid Receptors Type-1 and Type-2 as Key Effectors of Pro-Inflammatory Response 113
The endocannabinoid hydrolase FAAH is an allosteric enzyme 107
Assay of NAPE-PLD Activity 104
The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity 96
Lipid Discovery by Combinatorial Screening and Untargeted LC-MS/MS 81
Palmitoylation of cysteine 415 of CB1 receptor affects ligand-stimulated internalization and selective interaction with membrane cholesterol and caveolin 1 80
Plant-Derived and Endogenous Cannabinoids in Epilepsy 75
Bisphenol a deranges the endocannabinoid system of primary sertoli cells with an impact on inhibin b production 45
Biochimica del sangue 43
Endomorphin-1 prevents lipid accumulation via CD36 down-regulation and modulates cytokines release from human lipid-laden macrophages 38
Dynamic changes of anandamide in the cerebrospinal fluid of Parkinson's disease patients 34
Exploring the 1,3-benzoxazine chemotype for cannabinoid receptor 2 as a promising anti-cancer therapeutic 30
Selective Fatty Acid Amide Hydrolase Inhibitors as Potential Novel Antiepileptic Agents 30
Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1 20
Chemical proteomics reveals off-targets of the anandamide reuptake inhibitor WOBE437 17
Endocannabinoids and platelets - Signalling pathways 16
Endocannabinoids and platelets - Differentiation 16
In silico and in vitro analysis of major cannabis-derived compounds as fatty acid amide hydrolase inhibitors 15
Conformational Dynamics of Lipoxygenases and Their Interaction with Biological Membranes 13
Radiometric Assay of NAPE-PLD Activity 13
DNA-Protein-Interaction (DPI)-ELISA Assay for PPAR-γ Receptor Binding 13
Effects of Long-Term Oral Administration of N-Palmitoylethanolamine in Subjects with Mild Cognitive Impairment: Study Protocol 9
Totale 23.283
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.977
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.977
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.836 0 0 0 553 469 634 524 578 612 514 479 473
2020/20213.671 419 464 416 459 374 355 443 367 81 91 145 57
2021/2022824 19 91 38 43 19 71 37 33 54 110 82 227
2022/2023981 110 85 20 128 75 238 75 61 93 5 69 22
2023/2024318 30 11 15 15 27 87 8 23 2 3 38 59
2024/2025689 88 414 183 4 0 0 0 0 0 0 0 0
Totale 23.283